Gene · 406977
Papers1,599
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,599
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engineered MSC-Exosomes Delivering miRNAs for Respiratory Disease Diagnostics and Therapy: Opportunities and Challenges. | Int J Nanomedicine | 2026 | 41717313 | PubTator, text mining | PubMed |
| Exosomal miR-199a-3p derived from follicular fluid modulates the immune microenvironment in polycystic ovary syndrome by regulating macrophage polarization. | J Ovarian Res | 2026 | 41664118 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Derived microRNAs as Fluid Biomarkers in Neurodegenerative Diseases: A Systematic Review. | J Neurochem | 2026 | 41572495 | PubTator, text mining | PubMed |
| Mesenchymal stromal cell-derived extracellular vesicles in regenerative medicine: Standardisation, bioengineering and clinical translation. | Regen Ther | 2026 | 41537152 | PubTator, text mining | PubMed |
| Overview of exosomal non-coding RNAs in cardiovascular disease using high throughput sequencing. | Eur J Pharmacol | 2025 | 42640698 | PubTator, text mining | PubMed |
| Nutrigenomic influence of a curcumin-supplemented high glycemic diet on hippocampal microvasculature in male C57BL/6J mice. | Front Nutr | 2025 | 41710590 | PubTator, text mining | PubMed |
| Development of serum glycosylated exosomal microRNAs as biomarkers for early diagnosis of lung adenocarcinoma. | Front Med (Lausanne) | 2025 | 41451087 | PubTator, text mining | PubMed |
| P21-activated kinase 4: a potent oncogene, molecular mechanisms and opportunities for targeted therapy. | Cancer Cell Int | 2025 | 41250149 | PubTator, text mining | PubMed |
| 3D Bioprinting Functional Engineered Heart Tissues. | Int J Mol Sci | 2025 | 41226748 | PubTator, text mining | PubMed |
| Widely conserved miRNAs in buffalo milk extracellular vesicles survive gastrointestinal digestion and potentially target neural and immunomodulatory contexts. | Front Nutr | 2025 | 41178946 | PubTator, text mining | PubMed |
| Thymoquinone Upregulates microRNA-199a-3p and Downregulates COX-2 Expression and PGE2 Production via Deactivation of p38/ERK/JNK-MAPKs and p65/p50-NF-κB Signaling in Human Lung Cancer Cells. | Biology (Basel) | 2025 | 41154751 | PubTator, text mining | PubMed |
| Functional and in silico evidence for the role of microRNAs 148a-5p and 199a in migration and invasion of papillary thyroid carcinoma cells. | Discov Oncol | 2025 | 41134479 | PubTator, text mining | PubMed |
| Predictive Role of MicroRNAs in the Diagnosis and Management of Patients with Crohn's Disease: A Clinician's View. | Cells | 2025 | 41002400 | PubTator, text mining | PubMed |
| Analysis of miR-151a-3p as a biomarker of osteoarthritis and its clinical value. | J Orthop Surg Res | 2025 | 40993612 | PubTator, text mining | PubMed |
| Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2025 | 40830968 | PubTator, text mining | PubMed |
| Comparisons of miRNA profiles of exosomes derived from human iPSCs, ADSCs, and BMSCs and effects on chondrocyte function. | Bone Joint Res | 2025 | 40823751 | PubTator, text mining | PubMed |
| Adipose-Derived Exosomes: mediators of crosstalk between Adipose tissue and cancer. | Cancer Biol Ther | 2025 | 40817844 | PubTator, text mining | PubMed |
| Targeting tumor vascular endothelial cells for hepatocellular carcinoma treatment. | World J Gastroenterol | 2025 | 40809931 | PubTator, text mining | PubMed |
| Nanotechnology-driven platforms for extracellular vesicle analysis in tumor immunotherapy. | Front Immunol | 2025 | 40808949 | PubTator, text mining | PubMed |
| Quantification of transcript isoforms at the single-cell level using SCALPEL. | Nat Commun | 2025 | 40640129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406977/papers?page=2